|Bid||24.90 x 0|
|Ask||26.17 x 0|
|Day's range||25.39 - 25.56|
|52-week range||22.00 - 30.07|
|Beta (5Y monthly)||1.32|
|PE ratio (TTM)||15.97|
|Forward dividend & yield||1.17 (4.62%)|
|Ex-dividend date||26 May 2022|
|1y target est||N/A|
BERLIN (Reuters) -German chemicals company Evonik plans to invest 8 billion euros ($8.45 billion) by 2030 to boost growth in its smart materials, specialty additives and nutrition & care units, its chief executive said. Evonik's business in Russia will come to a standstill, CEO Christian Kullmann said. Methionine, an amino acid that Evonik produces in Russia and which is used as an animal-feed additive, is now on the European Union's embargo list, according to Kullmann.
Evonik Industries AG / Key word(s): Quarter Results/Preliminary ResultsEvonik Industries AG: Evonik publishes preliminary figures for the first quarter of 202221-Apr-2022 / 12:58 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Essen, April 21, 2022. Evonik Industries AG publishes already today the following preliminary key fi
Evonik said it would spend an amount in the "low three-digit million euros" but gave no further details on the actual sum to be invested. It said the new plant would strengthen its partnership with consumer goods group Unilever. Rhamnolipids, which are fully biodegradable substances produced by bacteria by fermentation of sugar, are not oil-based and allow the manufacture of environmentally friendly products including detergents and cleaning agents.